Who is sponsoring NCT02910726?

NCT02910726 is sponsored by Memorial Sloan Kettering Cancer Center.

What drugs are being tested in NCT02910726?

Interventions in NCT02910726: Sentinel Lymph Node Biopsy, indocyanine green (ICG).

What condition does NCT02910726 study?

NCT02910726 studies Pediatric Patients With Solid Tumors.

Is NCT02910726 still recruiting?

NCT02910726 is currently completed. Last updated 5 October 2022.

Are results published for NCT02910726?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2022-10-05 · How we verify

NCT02910726

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Study Comparing Green Fluorescent Dye and Radioactive Dye for Sentinel Lymph Node Biopsy in Pediatric Cancers

Completed Phase 2, PHASE3 Results posted Last updated 5 October 2022

What this trial tests

Phase 2, PHASE3 trial testing Sentinel Lymph Node Biopsy in Pediatric Patients With Solid Tumors in 6 participants. Completed in 2 September 2022.

Timeline

13 September 2016

Primary endpoint
2 September 2022

2 September 2022

Quick facts

Lead sponsor	Memorial Sloan Kettering Cancer Center
Phase	Phase 2, PHASE3
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	6
Start date	13 September 2016
Primary completion	2 September 2022
Estimated completion	2 September 2022
Sites	3 locations across United States

Drugs / interventions tested

Sentinel Lymph Node Biopsy
indocyanine green (ICG) — full drug profile →

Conditions studied

Pediatric Patients With Solid Tumors — all drugs for Pediatric Patients With Solid Tumors →

Sponsor

Memorial Sloan Kettering Cancer Center — full company profile →

Who can join

Under 30, any sex, with Pediatric Patients With Solid Tumors. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is being done in patients that have tumors to find out how well sentinel lymph nodes (SLNs) can be found with a special dye called indocyanine green (ICG).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Sentinel Lymph Node Biopsy

Trials testing the same drug.

NCT07121595 — Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cel · Phase 2 · recruiting
NCT05797415 — Sentinel Lymph Node Biopsy in Ocular Surface and Adnexal Cancers · recruiting
NCT04959474 — Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer · NA · recruiting
NCT05004623 — Early Feasibility Study of the "Easy Light" Fluorecence Imaging System · NA · completed
NCT04664582 — Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck · NA · unknown

Other Memorial Sloan Kettering Cancer Center trials

Trials by the same sponsor.

NCT07566377 — Cord Blood Transplantation in Children and Young Adults With Blood Cancer · Phase 2 · recruiting
NCT07507643 — A Study of Methylprednisolone in People Having Liver Surgery · Phase 3 · recruiting
NCT07483307 — A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Breast Cancer · Phase 2 · recruiting
NCT07459673 — HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term · Phase 2 · recruiting
NCT07449195 — A Study Comparing Two Optical Coherence Tomography Devices in People With Ocular Tumors · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02910726 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center
Last refreshed: 5 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02910726.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing